G3139

oblimersen · Genta Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for G3139, covering 2007-10-12 to 2007-10-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of G3139 Subcutaneous in Solid Tumors [Phase 1]